Search Results 531-540 of 17192 for alopecia
... alopecia). Patients must not have had nitrosoureas or mitomycin C for 6 weeks prior to the initiation of study treatment. Radiation: Prior radiation therapy ...
Unresolved toxicities from previous anticancer therapy, defined as toxicities (other than alopecia) not yet resolved to NCI-CTCAE Version 5.0, Grade ≤1 or ...
... Alopecia areata, Melasma, Vascular anomaly, Dermatitis, Morphea, Skin problems, Birthmarks, Vulvar skin disorder, Rosacea, Pigmentation disorder, Telogen ...
... Alopecia areata, Scarring alopecia, Tinea versicolor, Rosacea, Melasma, Vitiligo, Vascular malformation, Nonmelanoma skin cancer, Tuberous sclerosis ...
... Alopecia areata, Melasma. Show more areas of focus for Ashley B. Wentworth, M.D.. Josh P. Wiedermann, M.D.. Otolaryngologist. Rochester ...
Besch, M.D.. Dermatologist. Phoenix, AZ. Areas of focus: Acne, Skin cancer, Hidradenitis suppurativa, Dermatitis, Psoriasis, Alopecia areata, Rosacea, Vitiligo, ...
Natural History Evaluation Among Female Breast Cancer Survivors With Endocrine Therapy-Induced Alopecia. Mankato, Minn., Rochester, Minn., Albert Lea, Minn ...
... Alopecia areata, Seborrheic dermatitis, Melasma, Vitiligo. Show more areas of focus for Ashley B. Wentworth, M.D.. Josh P. Wiedermann ...
Dacarbazine belongs to the group of medicines called alkylating agents. It is used to treat cancer of the lymph system and malignant melanoma (a type of skin ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.